Statistics
Total Visits
| Views | |
|---|---|
| Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis—what is best in class? Authors’ reply | 72 |
Total Visits Per Month
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis—what is best in class? Authors’ reply | 3 | 1 | 1 | 0 | 2 | 4 | 0 |
Top country views
| Views | |
|---|---|
| United States | 45 |
| Poland | 4 |
| United Kingdom | 3 |
| Cyprus | 2 |
| France | 2 |
| Ireland | 2 |
| Argentina | 1 |
| China | 1 |
| Germany | 1 |
| Greece | 1 |
Top cities views
| Views | |
|---|---|
| Louisville | 23 |
| Boardman | 5 |
| San Ramon | 5 |
| Warsaw | 4 |
| Dublin | 2 |
| Limassol | 2 |
| San Jose | 2 |
| Ann Arbor | 1 |
| Athens | 1 |
| Costa Mesa | 1 |